ChemicalBook > CAS DataBase List > ONO7475

ONO7475

Product Name
ONO7475
CAS No.
1646839-59-9
Chemical Name
ONO7475
Synonyms
ONO7475;tamnorzatinib;ONO-7475 ,S8933;ONO-7475, 10 mM in DMSO;Tamnorzatinib (ONO-7475);N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide;3-Quinolinecarboxamide, N-[5-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-pyridinyl]-1,2,5,6,7,8-hexahydro-2,5-dioxo-1-phenyl-;N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide , Tamnorzatinib;lung,tumor,leukemia,inhibit,solid,Trk Receptor,tolerant,cancer,Mer,Tropomyosin related kinase receptor,NSCLC,TAM Receptor,EGFR,ONO 7475,Tyro3,advanced,ONO7475,mutunt,Inhibitor,Axl,TKI,acute,ONO-7475,metastatic
CBNumber
CB65867703
Molecular Formula
C32H26N4O6
Formula Weight
562.57
MOL File
1646839-59-9.mol
More
Less

ONO7475 Property

Boiling point:
804.0±65.0 °C(Predicted)
Density 
1.43±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
form 
A crystalline solid
pka
8.50±0.20(Predicted)
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0083699
Product name
ONO-7475
Purity
99.38%
Packaging
5mg
Price
$250
Updated
2021/12/16
ChemScene
Product number
CS-0083699
Product name
ONO-7475
Purity
99.38%
Packaging
10mg
Price
$350
Updated
2021/12/16
ChemScene
Product number
CS-0083699
Product name
ONO-7475
Purity
99.38%
Packaging
50mg
Price
$780
Updated
2021/12/16
DC Chemicals
Product number
013318
Product name
ONO-7475
Packaging
002
Price
$950
Updated
2021/12/16
DC Chemicals
Product number
013318
Product name
ONO-7475
Packaging
003
Price
$1900
Updated
2021/12/16
More
Less

ONO7475 Chemical Properties,Usage,Production

Uses

Tamnorzatinib (ONO-7475) is a potent, selective, and orally active Axl/Mer inhibitor with IC50 values of 0.7 nM and 1.0 nM, respectively. Tamnorzatinib sensitizes AXL-overexpressing EGFR-mutant NSCLC cells to the EGFR-TKIs, suppresses the emergence and maintenance of tolerant cells. Tamnorzatinib combines with Osimertinib (HY-15772) provides a bright promise for the study of EGFR-mutated non-small cell lung cancer (NSCLC).

in vivo

Tamnorzatinib (oral gavage; 10 mg/kg or combines with 5 mg/kg Osimertinib; 29 days) treatment alone has little effect on the tumor growth. Besides, Osimertinib alone causes tumor regression within one week, but the tumors reappear within three weeks. The combined initial treatment causes tumor regression and the size of tumors is maintained for 4 weeks. No apparent adverse events, including weight loss are observed during these treatments[1].

Animal Model:Mouse CDX model using high-AXL-expressing PC-9KGR cells (exon 19 deletion and the exon21-T790M mutation in EGFR)[1]
Dosage:10 mg/kg; once daily; 19 days
Administration:oral gavage
Result:Had little effects alone, but combined treatments significantly decreased tumor volume without reappear.

IC 50

TrkA; Axl; Tyro3; Mer

References

[1] Okura N, et al. ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in?EGFR-Mutated Non-Small Lung Cancer.Clin Cancer Res.?2020 Jan 17. DOI:10.1158/1078-0432.CCR-19-2321
[2] Ruvolo PP, et al. Anexelekto/MER tyrosine kinase?inhibitor?ONO-7475?arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.Haematologica.?2017 Dec;102(12):2048-2057. DOI:10.3324/haematol.2017.168856

ONO7475 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

ONO7475 Suppliers

Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Fax
028-81705658
Email
3003855609@qq.com
Country
China
ProdList
7778
Advantage
56
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4762
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Shanghai SuperLan Chemcial Technique Centre
Tel
0-2022843681 15618226720
Fax
+86-21-51601218
Email
chaolaichem@foxmail.com
Country
China
ProdList
12476
Advantage
58
Chengdu Saint - Kay Biotechnology Co., Ltd.
Tel
028-85157043 15882256948
Email
676046971@qq.com
Country
China
ProdList
4180
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel
86-571-88216897,88216896 13588875226
Fax
86-571-88216895
Email
sales@hzclap.com
Country
CHINA
ProdList
6312
Advantage
58

1646839-59-9, ONO7475Related Search:


  • ONO7475
  • 3-Quinolinecarboxamide, N-[5-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-pyridinyl]-1,2,5,6,7,8-hexahydro-2,5-dioxo-1-phenyl-
  • tamnorzatinib
  • N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide
  • lung,tumor,leukemia,inhibit,solid,Trk Receptor,tolerant,cancer,Mer,Tropomyosin related kinase receptor,NSCLC,TAM Receptor,EGFR,ONO 7475,Tyro3,advanced,ONO7475,mutunt,Inhibitor,Axl,TKI,acute,ONO-7475,metastatic
  • N-(5-((6,7-Dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide , Tamnorzatinib
  • ONO-7475, 10 mM in DMSO
  • Tamnorzatinib (ONO-7475)
  • ONO-7475 ,S8933
  • 1646839-59-9
  • C32H26N4O6